Tolerability of paracetamol.
The excellent tolerability of therapeutic doses of paracetamol (acetaminophen) is a major factor in the very wide use of the drug. The major problem in the use of paracetamol is its hepatotoxicity after an overdose. Hepatotoxicity has also been reported after therapeutic doses, but critical analysis indicates that most patients with alleged toxicity from therapeutic doses have taken overdoses. Importantly, prospective studies indicate that therapeutic doses of paracetamol are an unlikely cause of hepatotoxicity in patients who ingest moderate to large amounts of alcohol. Controlled clinical trials have found that paracetamol is very well tolerated by the gastrointestinal tract. While variable results have been found in case control studies, most studies have shown no change or a small increase in the relative risk of perforations, ulcer or bleeding in the upper gastrointestinal tract. However, associations between the use of paracetamol and gastrointestinal toxicity, as well as with chronic renal disease and asthma, are very likely to reflect biases in some case control studies. In particular, such biases may be caused by the perceived high tolerability of paracetamol in these diseases. The consequent use of paracetamol in these diseases states then leads to an apparent association between paracetamol and the disease. Despite metabolism of paracetamol to reactive compounds, hypersensitivity reactions are rare, although urticaria occurs in occasional patients. Paracetamol appears to be well tolerated during pregnancy although prospective studies are required.
Graham
Garry G
GG
Department of Clinical Pharmacology, St Vincent's Hospital, School of Medical Sciences, Sydney, Australia. ggraham@stvincents.com.au
Scott
Kieran F
KF
Day
Richard O
RO
D000082:Acetaminophen / Q000009:adverse effects* / Q000378:metabolism* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D006801:Humans; D015394:Molecular Structure; D016896:Treatment Outcome
D000082:Acetaminophen
Gut. 1976 Nov;17(11):916-9
1001981
J Clin Psychiatry. 2001;62 Suppl 20:32-41
11584873
Am J Ther. 2000 Mar;7(2):99-114
11319578
Ann Intern Med. 2001 Feb 20;134(4):345
11182855
Therapie. 1990 Sep-Oct;45(5):438-9
2260044
Drug Saf. 2001;24(11):829-41
11665870
Clin Psychol Rev. 2001 Jul;21(5):797-811
11434231
Gut. 1982 Aug;23(8):692-7
7095565
Ann Allergy Asthma Immunol. 1997 Jul;79(1):47-50
9236499
Ann Allergy Asthma Immunol. 2000 Dec;85(6 Pt 1):508-11
11152174
Semin Arthritis Rheum. 1989 Aug;19(1):22-30
2505388
Br J Clin Pharmacol. 1991 Aug;32(2):143-9
1931463
Postgrad Med. 2000 Jan;107(1):189-95
10649673
Arthritis Rheum. 1993 Jan;36(1):84-90
8424842
Cell. 1997 Oct 17;91(2):197-208
9346237
Adv Exp Med Biol. 1991;283:51-64
2069022
Arthritis Res. 2001;3(2):98-101
11178116
Am J Obstet Gynecol. 2002 Sep;187(3):653-60
12237643
Toxicol Appl Pharmacol. 1981 Nov;61(2):252-9
6798713
Clin Pharmacol Ther. 2000 Mar;67(3):275-82
10741631
Br J Clin Pharmacol. 2000 Apr;49(4):291-301
10759684
Am J Med. 1983 Jun 14;74(6A):79-82
6602547
Arch Intern Med. 2001 Oct 8;161(18):2247-52
11575982
Clin Exp Allergy. 2002 Sep;32(9):1366-9
12220477
Blood. 2001 Jun 15;97(12):3846-50
11389025
Br J Dermatol. 2000 Nov;143(5):1055-8
11069520
Lancet. 1998 Jan 10;351(9096):104-7
9439495
Br J Clin Pharmacol. 2002 Sep;54(3):320-6
12236853
Drug Saf. 2002;25(9):619-24
12137556
Am J Ther. 2000 Mar;7(2):55-61
11319574
Pharm Res. 1989 Apr;6(4):265-73
2664753
Chem Biol Interact. 1988;64(3):251-66
3124965
Ann Pharmacother. 2003 Oct;37(10):1497-501
14519044
Am J Gastroenterol. 1998 Jul;93(7):1051-4
9672328
Int J Cancer. 2002 Jan 1;97(1):96-101
11774249
BMJ. 2003 Aug 16;327(7411):368
12919986
Clin Pharmacol Ther. 2000 Jun;67(6):591-9
10872641
Toxicol Lett. 2001 Mar 31;120(1-3):199-208
11323178
Arthritis Rheum. 2001 Oct;44(10):2449; author reply 2455-6
11665990
J Toxicol Clin Toxicol. 2002;40(1):3-20
11990202
Ann N Y Acad Sci. 2001 Apr;932:200-21; discussion 221-4
11411187
Scand J Rheumatol Suppl. 1998;107:128-32
9759151
Arthritis Rheum. 2001 Oct;44(10):2448-9; author reply 2455-6
11665988
Am J Ther. 2002 May-Jun;9(3):199-205
11941379
N Engl J Med. 2001 Dec 20;345(25):1801-8
11752356
Am J Gastroenterol. 1985 Oct;80(10):767-9
4036935
Am J Ther. 2002 May-Jun;9(3):225-33
11941382
Thorax. 2000 Apr;55(4):266-70
10722764
Am J Hematol. 1994 Mar;45(3):258-9
8296799
Gut. 1999 Feb;44(2):270-3
9895389
Eur J Clin Pharmacol. 1979 Jul;15(6):427-31
499292
Arch Intern Med. 2002 Oct 28;162(19):2204-8
12390063
Hepatology. 1994 May;19(5):1141-8
8175135
Arthritis Rheum. 2000 Sep;43(9):1905-15
11014340
BMJ. 1995 Apr 1;310(6983):827-30
7711618
Curr Pharm Des. 2002;8(12):1063-75
11945151
Presse Med. 2001 Apr 21;30(15):724-30
11360737
Thromb Res. 1989 Mar 15;53(6):603-13
2499947
Arthritis Rheum. 2002 Nov;46(11):3046-54
12428249
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4611-6
11287661
Ir J Med Sci. 2001 Apr-Jun;170(2):94-7; discussion 90
11491059
Am J Kidney Dis. 1996 Jul;28(1 Suppl 1):S14-9
8669423
Med J Aust. 1999 Nov 1;171(9):472-5
10615340
Inflammopharmacology. 1999;7(3):255-63
17638096
Drug Saf. 1992;7 Suppl 1:51-6
1503678
Am J Ther. 2000 Mar;7(2):123-34
11319580
J Biol Chem. 1987 Jan 25;262(3):974-80
3100532
Clin Pharmacol Ther. 1983 Jan;33(1):95-101
6848304